As of 2025-07-04, the Relative Valuation of Vaxcyte Inc (PCVX) is (52.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.27 USD, the upside of Vaxcyte Inc based on Relative Valuation is -259.2%.
The range of the Relative Valuation is (52.27) - (73.61) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 18.6x | 13.1x |
| Forward P/E multiples | 13.2x - 21.2x | 13.7x |
| Fair Price | (52.27) - (73.61) | (52.98) |
| Upside | -257.1% - -321.3% | -259.2% |
| Date | P/E |
| 2025-07-02 | -8.42 |
| 2025-07-01 | -8.33 |
| 2025-06-30 | -8.22 |
| 2025-06-27 | -8.24 |
| 2025-06-26 | -8.32 |
| 2025-06-25 | -8.37 |
| 2025-06-24 | -8.62 |
| 2025-06-23 | -8.41 |
| 2025-06-20 | -8.31 |
| 2025-06-18 | -8.45 |
| 2025-06-17 | -8.51 |
| 2025-06-16 | -8.68 |
| 2025-06-13 | -8.74 |
| 2025-06-12 | -8.72 |
| 2025-06-11 | -8.96 |
| 2025-06-10 | -9.41 |
| 2025-06-09 | -9.41 |
| 2025-06-06 | -9.36 |
| 2025-06-05 | -8.80 |
| 2025-06-04 | -8.56 |
| 2025-06-03 | -8.76 |
| 2025-06-02 | -8.86 |
| 2025-05-30 | -8.22 |
| 2025-05-29 | -8.30 |
| 2025-05-28 | -7.94 |
| 2025-05-27 | -8.03 |
| 2025-05-23 | -8.23 |
| 2025-05-22 | -8.59 |
| 2025-05-21 | -8.59 |
| 2025-05-20 | -9.25 |
| 2025-05-19 | -8.10 |
| 2025-05-16 | -8.06 |
| 2025-05-15 | -7.82 |
| 2025-05-14 | -7.44 |
| 2025-05-13 | -7.60 |
| 2025-05-12 | -7.99 |
| 2025-05-09 | -7.88 |
| 2025-05-08 | -7.95 |
| 2025-05-07 | -7.34 |
| 2025-05-06 | -7.40 |
| 2025-05-05 | -8.67 |
| 2025-05-02 | -8.95 |
| 2025-05-01 | -8.91 |
| 2025-04-30 | -9.07 |
| 2025-04-29 | -8.79 |
| 2025-04-28 | -8.32 |
| 2025-04-25 | -8.33 |
| 2025-04-24 | -8.73 |
| 2025-04-23 | -8.39 |
| 2025-04-22 | -7.91 |